## [About](/about "About") Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. ![grandfather-grandson-hugging](/sites/novartis_jobapi/files/styles/cta_image/public/2024-01/grandfather-grandson-hugging.jpg.webp?itok=XDtBjPPy "grandfather-grandson-hugging") ## Our purpose ## Reimagine medicine to improve and extend people's lives. ![family-looking-at-sunset](/sites/novartis_jobapi/files/styles/cta_image/public/2024-01/family-looking-at-sunset.jpg.webp?itok=DuxBHkkx "family-looking-at-sunset") ## Our vision ## Become the most valued and trusted medicines company in the world. ![group-of-women-from-indigenous-community-health-workshop-colombia](/sites/novartis_jobapi/files/styles/cta_image/public/2024-01/group-of-women-from-indigenous-community-health-workshop-colombia.jpg.webp?itok=-ePeTd6U "group-of-women-from-indigenous-community-health-workshop-colombia") ## Our strategy ## Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. ## Our footprint 78k #### Employees\* 130 #### Countries\*\* 250m+ #### Patients reached\*\*\* ## We focus on core therapeutic areas with high unmet patient needs Previous Next [ ![hcp-discussing-with-smilling-senior-patient-card](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/hcp-discussing-with-smilling-senior-patient-card.jpg.webp?itok=zSPsbXAf "hcp-discussing-with-smilling-senior-patient-card") ### Cardiovascular, renal and metabolic Transforming how the world tackles cardiovascular disease and delivering new treatments for people with chronic kidney diseases. ](https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic) [ ![HCP taking patient's blood pressure](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/hcp-taking-patient-blood-pressure-card_0.jpg.webp?itok=eZpl-pza "HCP taking patient's blood pressure") ### Immunology Working to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise. ](https://www.novartis.com/about/therapeutic-areas/immunology) [ ![Nurse and patient exchanging a warm moment](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/nurse-patient-exchanging-warm-moment-card.jpg.webp?itok=emAv9udJ "Nurse and patient exchanging a warm moment") ### Neuroscience Committed to change the course of disease progression in neuroscience. ](https://www.novartis.com/about/therapeutic-areas/neuroscience) [ ![Doctor and patient interacting over medical results](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/doctor-patient-interacting-medical-results-card.jpg.webp?itok=hpFbfN5H "Doctor and patient interacting over medical results") ### Oncology Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones. ](https://www.novartis.com/about/therapeutic-areas/oncology) ## and technology platforms that enable cutting-edge innovative therapies Previous Next ![Blue gradient icon of a flask](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/chemistry-card-blue-gradient-icon-3.jpg.webp?itok=w34BWznn "Blue gradient icon of a flask") ### Chemistry Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines. ![Blue gradient icon of an antibody](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/antibody-blue-gradient-icon.jpg.webp?itok=tBueERe6 "Blue gradient icon of an antibody") ### Biotherapeutics Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases. ![Blue gradient icon of a seringue](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/seringue-blue-gradient-icon.jpg.webp?itok=pdAlNlOJ "Blue gradient icon of a seringue") ### xRNA RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses. ![Blue gradient icon of an atom](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/atom-blue-gradient-icon.jpg.webp?itok=iXqfcOzo "Blue gradient icon of an atom") ### Radioligand therapy Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue. ![Blue gradient icon of a gene](/sites/novartis_jobapi/files/styles/cards_1_3/public/2024-01/gene-blue-gradient-icon.jpg.webp?itok=iECtDjqf "Blue gradient icon of a gene") ### Gene and cell therapy Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body. ## In this new era, we’re ready. Together, let’s reimagine medicine to improve and extend people’s lives. [ ![vas-narasimhan-big-image](/sites/novartis_jobapi/files/styles/cards_1_3/public/2021-07/vas-narasimhan-big-image.jpg.webp?itok=JakLYLDk "vas-narasimhan-big-image") ### Leadership The ability to attract, grow and keep talented people is vital for us to execute our strategy and keep developing innovative products that produce better results for patients. ](/about/country-leadership-team) [ ![Four colleagues sitting around a table at the office](/sites/novartis_jobapi/files/styles/cards_1_3/public/2022-03/colleagues-in-office-people-and-culture.jpg.webp?itok=Vy1Oz6Mu "Colleagues in the office") ### People and Culture We must fundamentally reimagine the way we work and create a culture that brings out the best in our people to fulfill our purpose of reimagining medicine. ](/about/people-and-culture) [ @novartis ](https://twitter.com/digital/status/2079453667401355685)2 Months 2 Weeks ago [\*Please see detailed guidance assumptions on page 7 of our Q2 press release. Link: https://t.co/qAj4ZZGKU2](https://twitter.com/digital/status/2079453667401355685 "*Please see detailed guidance assumptions on page 7 of our Q2 press release. Link: https://t.co/qAj4ZZGKU2") [ @novartis ](https://twitter.com/digital/status/2079452594385097003)2 Months 2 Weeks ago [\#Investors: Novartis delivered a solid second quarter, returning to sales growth driven by continued momentum from priority brands. We remain on track to deliver our full-year guidance and mid-term outlook.\* Press release: https://t.co/AWqyHGRWD3 Webcast: https://t.co/kncrWyBJL6](https://twitter.com/digital/status/2079452594385097003 "#Investors: Novartis delivered a solid second quarter, returning to sales growth driven by continued momentum from priority brands. We remain on track to deliver our full-year guidance and mid-term outlook.* Press release: https://t.co/AWqyHGRWD3 Webcast: https://t.co/kncrWyBJL6") ![YfSVvQ88EfgwQuYx](https://pbs.twimg.com/amplify_video_thumb/2079452566564360192/img/YfSVvQ88EfgwQuYx.jpg "YfSVvQ88EfgwQuYx") [ @novartis ](https://twitter.com/digital/status/2079431175664238593)2 Months 2 Weeks ago [\#NVSQ226 Novartis social media posts on Q2 2026 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ226 Novartis social media posts on Q2](https://twitter.com/digital/status/2079431175664238593 "#NVSQ226 Novartis social media posts on Q2 2026 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ226 Novartis social media posts on Q2") [ @novartis ](https://twitter.com/digital/status/2079102759215698244)2 Months 2 Weeks ago [On Tuesday, July 21, Novartis will announce its Q2 2026 results. Register to listen here: https://t.co/LIilPfqDRK #NovartisNews $NVS $NOVN #NVSQ226 https://t.co/sqBEM4SRYE](https://twitter.com/digital/status/2079102759215698244 "On Tuesday, July 21, Novartis will announce its Q2 2026 results. Register to listen here: https://t.co/LIilPfqDRK #NovartisNews $NVS $NOVN #NVSQ226 https://t.co/sqBEM4SRYE") ![HNlVYscXsAA6d5b](https://pbs.twimg.com/media/HNlVYscXsAA6d5b.jpg "HNlVYscXsAA6d5b") [ @novartis ](https://twitter.com/digital/status/2049013241939157200)5 Months 1 Week ago [\#Investors: Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We remain on track to deliver our full year guidance. Press release: https://t.co/c3x8o96Gsf IR Webcast: https://t.co/u5UJehcvf6](https://twitter.com/digital/status/2049013241939157200 "#Investors: Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We remain on track to deliver our full year guidance. Press release: https://t.co/c3x8o96Gsf IR Webcast: https://t.co/u5UJehcvf6") ![905f6Zb0PSnYbUqK](https://pbs.twimg.com/amplify_video_thumb/2049000808990355456/img/905f6Zb0PSnYbUqK.jpg "905f6Zb0PSnYbUqK") 1. 2. 3. 4. 5. [ Previous](#card3-paragraph--4341) [ Next](#card3-paragraph--4341) [ ![A photo of people in a meeting hall](/sites/novartis_jobapi/files/styles/cards_50_50/public/2021-11/photo-of-people-in-a-meeting-hall.jpg.webp?itok=KXlbeYPS "A photo of people in a meeting hall") ### Contact Find information on our research locations and corporate offices in XXXX. ](/about/contact) [ ![join-us-hero-image](/sites/novartis_jobapi/files/styles/cards_50_50/public/2021-07/join-us-hero-image.jpg.webp?itok=LwX7-CGO "join-us-hero-image") ### Careers 766 million lives touched by our products. ](/careers) ## Resource links [Pipeline](https://www.novartis.com/research-development/novartis-pipeline "Pipeline") [Impact](https://www.novartis.com/environmental-social-and-governance "Impact") [Leadership](https://www.novartis.com/about/executive-committee "Leadership") \*Based on 2022 data except for employees which has been restated to exclude Sandoz \*\* Based on 2022 data, excluding Sandoz \*\*\* Based on 2022 data, excluding Sandoz: 236 million patients reached with innovative medicines; 54 million patients reached through Novartis Global Health, which focuses on transforming health in low- and middle-income countries.